Icon ($ICLR) and Medidata ($MDSO) have teamed up to combine their patient-reported outcome (PRO) capabilities. Medidata is providing the underlying technology, while Icon is contributing its pre-validated surveys. The goal is to make PROs applicable to a wider range of trials and eliminate some of the difficulties sponsors commonly face when adopting the approach. Release